Minimally effective concentration of zoledronic acid to suppress osteoclasts in vitro.

about

Minimally effective concentration of zoledronic acid to suppress osteoclasts in vitro.

Item

http://www.wikidata.org/entity/Q55394728

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Minimally effective concentration of zoledronic acid to suppress osteoclasts in vitro.

@en

Minimally effective concentration of zoledronic acid to suppress osteoclasts in vitro.

@nl

type

Item

label

Minimally effective concentration of zoledronic acid to suppress osteoclasts in vitro.

@en

Minimally effective concentration of zoledronic acid to suppress osteoclasts in vitro.

@nl

prefLabel

Minimally effective concentration of zoledronic acid to suppress osteoclasts in vitro.

@en

Minimally effective concentration of zoledronic acid to suppress osteoclasts in vitro.

@nl

P1476

Minimally effective concentration of zoledronic acid to suppress osteoclasts in vitro.

@en

P2093

Chengrui Nan

http://www.w3.org/2001/XMLSchema#string

Hanjie Liu

http://www.w3.org/2001/XMLSchema#string

Litao Wang

http://www.w3.org/2001/XMLSchema#string

Pengfei Li

http://www.w3.org/2001/XMLSchema#string

Xianhui Jin

http://www.w3.org/2001/XMLSchema#string

Yaxin Shen

http://www.w3.org/2001/XMLSchema#string

Zongmao Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

An intrapleural administration of zoledronic acid for inoperable malignant mesothelioma patients: a phase I clinical study protocol

Influence of Zoledronic Acid on Atrial Electrophysiological Parameters and Electrocardiographic Measurements.

Effect of the cumulative dose of zoledronic acid on the pathogenesis of osteonecrosis of the jaws.

The Efficacy of Bisphosphonates for Prevention of Osteoporotic Fracture: An Update Meta-analysis.

New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effects.

The effects of zoledronic acid in the bone and vasculature support of hematopoietic stem cell niches

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.

Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.

Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials

Combined zoledronic acid and meloxicam reduced bone loss and tumour growth in an orthotopic mouse model of bone-invasive oral squamous cell carcinoma.

P304

5330-5336

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2018.6120

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29904413

http://www.w3.org/2001/XMLSchema#string

P932

5996712

http://www.w3.org/2001/XMLSchema#string